Dissimilarity in gene expression profiles of lung adenocarcinoma in japanese men and women

Gender Medicine

Volumn 3, Issue 3, 2006, Pages 223-235

  Okamoto, Junichi ^a   Onda, Masamitsu ^a   Hirata, Tomomi ^a   Miyamoto, Shizuyo ^a   Akaishi, Junko ^a   Mikami, Iwao ^a   Hirai, Kyoji ^a   Haraguchi, Shuji ^a   Koizumi, Kiyoshi ^a   Shimizu, Kazuo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

expression; gender; lung adenocarcinoma; oligonucleotide microarray

Indexed keywords

ALPHA TUBULIN; CELL PROTEIN; CHAPERONIN; CYCLINE; CYTOSOLIC OVARIAN CARCINOMA ANTIGEN 1; DELTA ADAPTIN; DNA; GLUTAMINASE; GLUTAMINASE 2; HLA DM ANTIGEN; HOMEODOMAIN PROTEIN; HOMEODOMAIN PROTEIN D8; IMMUNOGLOBULIN A; IMMUNOGLOBULIN HEAVY CHAIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NONMETASTATIC CELL 2 PROTEIN; RAN PROTEIN; RIBOSOME PROTEIN; RIBOSOME PROTEIN L13; RIBOSOME PROTEIN S21; RIBOSOME PROTEIN S3; SMALL NUCLEAR RIBONUCLEOPROTEIN; SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE B2; TUBULIN; TUBULIN TYROSINE LIGASE LIKE PROTEIN 11; TUMOR ANTIGEN; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL BETA1; WAP FOUR DISULFIDE CORE DOMAIN 2;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CELL CYCLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST; DNA MICROARRAY; FEMALE; GENDER BIAS; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; JAPAN; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; MALE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TREATMENT PLANNING; UBIQUITINATION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; RNA, NEOPLASM; SEX FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 33750361721     PISSN: 15508579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1550-8579(06)80210-X     Document Type: Article

References (43)

1. Fu J.B., Kau T.Y., Severson R.K., and Kalemkerian G.P. Lung cancer in women: Analysis of the national Surveillance, Epidemiology, and End Results database. Chest 127 (2005) 768-777
2. Sekine I., Nishiwaki Y., Yokose T., et al. Young lung cancer patients in Japan: Different characteristics between the sexes. Ann Thorac Surg. 67 (1999) 1451-1455
3. [in Spanish]. Santos-Martinez M.J., Curull V., Balanco M.L., et al. Lung cancer at a university hospital: Epidemiological and histological characteristics of a recent and a historical series. Arch Bronconeumol 41 (2005) 307-312
4. Patel J.D., Bach P.B., and Kris M.G. Lung cancer in US women: A contemporary epidemic. JAMA 291 (2004) 1763-1768
5. Chen K.Y., Chang C.H., Yu C.J., et al. Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma. Cancer 103 (2005) 2566-2574
6. Ranson M., Hammond L.A., Ferry D., et al. ZD1839, a selective oral epidermal growth factor receptortyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: Results of a phase I trial. J Clin Oncol. 20 (2002) 2240-2250
7. [published correction appears in I Clin Oncol. 2004;22:4811]. Fukuoka M., Yano S., Giaccone G., et al. Multiinstitutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial). J Clin Oncol. 21 (2003) 2237-2246
8. Paez J.G., Janne P.A., Lee J.C., et al. EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy. Science 304 (2004) 1497-1500
9. Travis W.D., Colby T.V., Corrin B., et al. WHO International Histological Classification of Tumors: Histological Typing of Lung and Pleural Tumors. 3rd ed (1999), Springer-Verlag, Berlin, Germany
10. Onda M., Emi M., Yoshida A., et al. Comprehensive gene expression profiling of anaplastic thyroid cancers with cDNA microarray of 25 344 genes. Endocr Relat Cancer. 11 (2004) 843-854
11. Onda M., Emi M., Nagai H., et al. Gene expression patterns as marker for 5-year postoperative prognosis of primary breast cancers. J Cancer Res Clin Oncol. 130 (2004) 537-545
12. Tsai C.A., Chen Y.J., and Chen J.J. Testing for differentially expressed genes with microarray data. Nucleic Acids Res 31 (2003) e52
13. Cleveland W.S. Robust locally weighted regression and smoothing scatterplots. J Amer Stat Assoc. 74 (1979) 829-836
14. (Suppl). Quackenbush J. Microarray data normalization and transformation. Nat Genet. 32 (2002) 496-501.
15. Eisen M.B., Spellman P.T., Brown P.O., and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95 (1998) 14863-14868
16. Onda M., Akaishi J., Asaka S., et al. Decreased expression of hemoglobin beta (HBB) gene in anaplastic thyroid cancer and recovery of its expression inhibits cell growth. Br J Cancer 92 (2005) 2216-2224
17. Onda M., Nagai H., Yoshida A., et al. Up-regulation of transcriptional factor E2F1 in papillary and anaplastic thyroid cancers. J Hum Genet. 49 (2004) 312-318
18. National Center for Biotechnology Information. GenBank. Available at: http://www.ncbi.nlm.nih.gov/entryfcgi?db=Nucleotide&cmd=search&term=nucleotide.
19. Sasaki S., Nakamura T., Arakawa H., et al. Isolation and characterization of a novel gene, hRFI, preferentially expressed in esophageal cancer. Oncogene 21 (2002) 5024-5030
20. Budde L.M., Wu C., Tilman C., et al. Regulation of IkappaBbeta expression in testis. Mol Biol Cell 13 (2002) 4179-4194
21. Morre D.J., Sedlak D., Tang X., et al. Surface NADH oxidase of HeLa cells lacks intrinsic membrane binding motifs. Arch Biochem Biophys 392 (2001) 251-256
22. Harari P.M., and Huang S.M. Searching for reliable epidermal growth factor receptor response predictors. Cancer Res 10 (2004) 428-432
23. Godfried M.B., Veenstra M., van Sluis P., et al. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23H2. Oncogene 21 (2002) 2097-2101
24. Mitsudomi T., Kosaka T., Endoh H., et al. Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in pa tients with non-small-cell lung cancer with post-operative recurrence. J Clin Oncol. 23 (2005) 2513-2520
25. Bach P.B., Cramer L.D., Warren J.L., and Begg C.B. Racial differences in the treatment of early-stage lung cancer. N Engl J Med 341 (1999) 1198-1205
26. Alexiou C., Onyeaka C.V., Beggs D., et al. Do women live longer following lung resection for carcinoma?. Eur J Cardiothorac Surg. 21 (2002) 319-325
27. Ferguson M.K., and Karrison T. Does pneumonectomy for lung cancer adversely influence long-term survival?. J Thorac Cardiovasc Surg. 119 (2000) 440-448
28. de Perrot M., Licker M., Bouchardy C., et al. Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma. J Thorac Cardiovasc Surg. 119 (2000) 21-26
29. Girard L., Zochbauer-Muller S., Virmani A.K., et al. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res. 60 (2000) 4894-4906
30. Shimizu S., and Mitsudimi T. Molecular abnormalities of lung cancer. Nippon Rinsho. 60 Suppl 5 (2002) 73-77
31. Hansen J.J., Bross P., Westergaard M., et al. Genomic structure of the human mitochondrial chaperonin genes: HSP60 and HSP10 are localised head to head on chromosome 2 separated by a bidirectional promoter. Hum Genet. 112 (2003) 71-77
32. Endo C., Sagawa M., Sato M., et al. Sequential loss of heterozygosity in the progression of squamous cell carcinoma of the lung. Br J Cancer. 78 (1998) 612-615
33. Cappello F., Bellafiore M., David S., et al. Ten kilodalton heat shock protein (HSP10) is overexpressed during carcinogenesis of large bowel and uterine exocervix. Cancer Lett. 196 (2003) 35-41
34. Clauss A., Lilja H., and Lundwall A. A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein. Biochem J. 368 (2002) 233-242
35. Hellstrom I., Raycraft J., Hayden-Ledbetter M., et al. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res. 63 (2003) 3695-3700
36. Tanner M.M., Grenman S., Koul A., et al. Frequent amplification of chromosomal region 20gl2-ql3 in ovarian cancer. Clin Cancer Res. 6 (2000) 1833-1839
37. Diebold J., Mosinger K., Peiro G., et al. 20813 and cyclin D1 in ovarian carcinomas. Analysis by fluorescence in situ hybridization. J Pathol. 190 (2000) 564-571
38. Kersemaekers A.M., van de Vijver M.J., Kenter G.G., and Fleuren G.J. Genetic alterations during the progression of squamous cell carcinomas of the uter ine cervix. Genes Chromosomes Cancer 26 (1999) 346-354
39. Mazurenko N., Attaleb M., Gritsko T., et al. High resolution mapping of chromosome 6 deletions in cervical cancer. Oncol Rep. 6 (1999) 859-863
40. Chatterjee A., Pulido H.A., Koul S., et al. Mapping the sites of putative tumor suppressor genes at 6p25 and 6p21.3 in cervical carcinoma: Occur rence of allelic deletions in precancerous lesions. Cancer Res. 61 (2001) 2119-2123
41. Virmani A.K., Fong K.M., Kodagoda D., et al. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types. Genes Chromosomes Cancer 21 (1998) 308-319
42. Caputi M., Esposito V., Groger A.M., et al. Prognostic role of proliferating cell nuclear antigen in lung cancer: An immunohistochemical analysis. In Vivo 12 (1998) 85-88
43. Fukami-Kobayashi J., and Mitsui Y. Overexpression of proliferating cell nuclear antigen in mammalian cells negates growth arrest by serum starvation and cell contact. Jpn J Cancer Res. 90 (1999) 286-293